We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

4 hedge funds and large institutions have $1.78M invested in Innovator IBD ETF Leaders ETF in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more capital invested

Capital invested by funds: $1.11M → $1.78M (+$669K)

0% more funds holding

Funds holding: 44 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OMC
1
Old Mission Capital
Illinois
$1.3M +$1.39M +48,440 New
LPL Financial
2
LPL Financial
California
$356K +$381K +13,312 New
UBS Group
3
UBS Group
Switzerland
$67K +$61.4K +2,146 +603%
Osaic Holdings
4
Osaic Holdings
Arizona
$64K
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$1.04M -36,204 Closed
Wells Fargo
6
Wells Fargo
California
-$29 -1 Closed

LDRS Hedge Fund Activity: Q1 2021 in Review

4 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2021, worth a combined $1.78M — up 60% from $1.11M a quarter earlier.

Fund positioning in LDRS was balanced in Q1 2021: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Old Mission Capital, opening a new position worth an estimated $1.39M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.04M sold.

  • 4 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2021, unchanged from Q4 2020.
  • Funds reported $1.78M of Innovator IBD ETF Leaders ETF stock for Q1 2021, up 60% quarter-over-quarter.
  • 2 funds opened new Innovator IBD ETF Leaders ETF positions in Q1 2021 and 2 closed out, a net change of 0 holders.
  • The largest Innovator IBD ETF Leaders ETF buyer in Q1 2021 was Old Mission Capital, an estimated $1.39M added.
  • The largest Innovator IBD ETF Leaders ETF seller in Q1 2021 was Susquehanna International Group, an estimated $1.04M sold.

Based on aggregated 13F filings for Q1 2021.